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Letters to the
Editor
Vein graft neointimal hyperplasia:
Prevention is better than cure
To the Editor:
We read with interest the article by Thomas
Schachner.1 This review was an excellent
description of the multiple factors involved
in the initiation and progression of neoin-
timal hyperplasia in vein grafts during cor-
onary bypass surgery. Clearly much has
been learned in recent years about the type
and origin of the cells composing the hyper-
plastic tissue and other various factors in-
volved in the hyperplastic process. Schachner
has proposed multiple pharmacologic strate-
gies to reduce this hyperplastic process.
However, we contend that this approach
is similar to closing the stable door after the
horse has bolted. Surely it is better to pre-
vent the damage to the vein in the first
place than to try to reverse the results in
terms of neointimal hyperplasia after the
damage has been done. There is a wealth of
literature showing the adverse effects of
surgical trauma, especially high pressure
distension during vein graft harvesting, on
the subsequent fate to the vein graft.2
However, surgeons know instinctively
that before they can implant a vein graft it
must have an adequate lumen and be free of
spasm. If vein spasm is present then the sur-
geon invariably uses sufficient pressure to
remove the spasm. We and others have
shown that this procedure of distending the
vein can generate extremely high intralu-
minal pressures and lead to widespread loss
of endothelial coverage.2,3 We have also
shown that this loss of endothelium can be
prevented by pharmacologic relaxation of
the vein with appropriate vasodilator agents.4
We have shown in an extensive series
of organ bath studies and clinical trials that
a mixture of glyceryl trinitrate and vera-
pamil is a highly effective means of reduc-
ing vein graft spasm. This combination ret
laxes the saphenous vein by 2 mechanisms.
It has a rapid onset of effect and a long
duration of action.5 A more commonly used
pharmacologic agent is papaverine. How-
ever, we have shown that this agent results in
inferior preservation of the endothelium.4
Papaverine also has a number of other
undesirable effects, especially endothelial
damage from the acidity of its solution,
particularly if it is undiluted.6 Recent stud-
ies have shown other adverse effects of
papaverine on the endothelium.6 Papaver-
ine, however, continues to be used because
it is readily available in the operating room.
Although pharmacologic inhibition of
vein graft neointimal hyperplasia is possi-
ble, it is more important to prevent it in the
first place by using pharmacologic relaxation
of the vein graft conduit during harvesting.
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The Editor welcomes submissions for
possible publication in the Letters to the
Editor section that consist of commen-
tary on an article published in the Jour-
nal or other relevant issues. Authors
should:
● Include no more than 500 words of text,
three authors, and five references
● Type with double-spacing
● See http://jtcs.ctsnetjournals.org/misc/
ifora.shtml for detailed submission
instructions.
● Submit the letter electronically via
jtcvs.editorialmanager.com.
Letters commenting on an article pub-
lished in the JTCVS will be considered if
they are received within 6 weeks of the
time the article was published. Authors
of the article being commented on will be
given an opportunity to offer a timely
response (2 weeks) to the letter. Authors
of letters will be notified that the letter
has been received. Unpublished letters
cannot be returned.
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